Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EVKG Ever-Glory International Group	$0.00	$0.00	$0.00 ▼ $0.01	$10K	3.74	15,420 shs	14 shs
MGOL MGO Global	$0.31 -33.8%	$0.31	$0.10 ▼ $17.30	$894K	7.26	24.22 million shs	106.10 million shs
ONON ON	$52.35 -6.1%	$51.23	$34.59 ▼ $64.05	$32.96B	2.35	4.59 million shs	9.33 million shs
SILO Silo Pharma	$0.59 -3.7%	$0.78	$0.41 ▼ $4.50	$2.63M	0.02	2.36 million shs	237,276 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EVKG Ever-Glory International Group	0.00%	0.00%	0.00%	-93.00%	0.00%
MGOL MGO Global	0.00%	0.00%	0.00%	0.00%	-93.57%
ONON ON	-1.98%	-2.09%	-2.87%	+20.15%	+27.80%
SILO Silo Pharma	+3.41%	-4.67%	-44.54%	-55.79%	-44.79%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONON ON	3.4879 of 5 stars	3.5	2.0	0.0	0.0	2.8	1.7	2.5
SILO Silo Pharma	1.8173 of 5 stars	0.0	5.0	0.0	0.0	3.3	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EVKG Ever-Glory International Group	0.00	N/A	N/A	N/A
MGOL MGO Global	0.00	N/A	N/A	N/A
ONON ON	3.00	Buy	$63.05	20.44% Upside
SILO Silo Pharma	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest MGOL, SILO, EVKG, and ONON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/14/2025	ONON ON	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$75.00
5/14/2025	ONON ON	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/14/2025	ONON ON	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy
5/14/2025	ONON ON	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$68.00
5/14/2025	ONON ON	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$60.00 ➝ $70.00
5/14/2025	ONON ON	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$61.00 ➝ $69.00
5/14/2025	ONON ON	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$57.00 ➝ $66.00
5/14/2025	ONON ON	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$60.00 ➝ $68.00
5/14/2025	ONON ON	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$63.00 ➝ $70.00
5/14/2025	ONON ON	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$55.00 ➝ $62.00

(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	$5.20M	0.17	N/A	N/A	$0.64 per share	0.48
ONON ON	$2.54B	12.99	$0.26 per share	200.39	$1.90 per share	27.55
SILO Silo Pharma	$72.10K	36.53	N/A	N/A	$2.14 per share	0.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EVKG Ever-Glory International Group	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	-$7.14M	-$4.57	N/A	∞	N/A	-142.93%	-412.85%	-291.72%	N/A
ONON ON	$88.67M	$0.70	121.74	60.87	1.02	5.87%	10.69%	6.66%	8/12/2025 (Estimated)
SILO Silo Pharma	-$3.70M	-$1.17	N/A	∞	N/A	-5,255.05%	-61.38%	-47.49%	8/11/2025 (Estimated)

Latest MGOL, SILO, EVKG, and ONON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/9/2025	Q1 2025	SILO Silo Pharma	N/A	-$0.23	N/A	-$0.23	N/A	$0.02 million
3/28/2025	Q4 2024	SILO Silo Pharma	N/A	-$0.41	N/A	-$0.41	N/A	$0.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A
ONON ON	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EVKG Ever-Glory International Group	N/A	N/A	N/A
MGOL MGO Global	N/A	14.13	8.37
ONON ON	N/A	2.91	2.25
SILO Silo Pharma	N/A	7.91	7.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EVKG Ever-Glory International Group	N/A
MGOL MGO Global	1.05%
ONON ON	36.39%
SILO Silo Pharma	5.58%

Insider Ownership

Company	Insider Ownership
EVKG Ever-Glory International Group	35.53%
MGOL MGO Global	12.60%
ONON ON	68.57%
SILO Silo Pharma	4.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EVKG Ever-Glory International Group	4,300	14.66 million	N/A	Not Optionable
MGOL MGO Global	7	2.90 million	2.54 million	Not Optionable
ONON ON	1,160	629.65 million	197.90 million	Optionable
SILO Silo Pharma	2	4.48 million	4.29 million	Not Optionable

MGOL, SILO, EVKG, and ONON Headlines

Recent News About These Companies

Reviewing Silo Pharma (NASDAQ:SILO) and Upstream Bio (NASDAQ:UPB)

June 13 at 2:29 AM | americanbankingnews.com

Silo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11 at 8:18 PM | finanznachrichten.de

Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD

June 11 at 9:19 AM | quiverquant.com

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11 at 9:00 AM | globenewswire.com

16 Companies Announced A Bitcoin Treasury Last Week: Report

June 9, 2025 | coingape.com

Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset

June 7, 2025 | nasdaq.com

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

June 5, 2025 | globenewswire.com

Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine

June 2, 2025 | newsfilecorp.com

Silo Pharma, Inc.: Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 23, 2025 | finanznachrichten.de

Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug

May 21, 2025 | msn.com

Silo Pharma, Inc. Partners with Resyca BV for SPC-15 Drug-Device Study Aimed at PTSD Treatment

May 21, 2025 | quiverquant.com

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025 | globenewswire.com

Silo Pharma, Inc.: Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 16, 2025 | finanznachrichten.de

Silo Pharma Signs With Frontage Labs For FDA Requested Safety Study Of SPC-15

May 16, 2025 | nasdaq.com

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025 | globenewswire.com

Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment

May 16, 2025 | msn.com

Silo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated Warrants

May 15, 2025 | quiverquant.com

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025 | globenewswire.com

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025 | globenewswire.com

Silo Pharma, Inc. Announces Agreement with Frontage Laboratories for SPC-15 Safety and Toxicology Study Targeting PTSD Treatment

May 14, 2025 | quiverquant.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MGOL, SILO, EVKG, and ONON Company Descriptions

Ever-Glory International Group NASDAQ:EVKG

$0.0007 0.00 (0.00%)

As of 06/12/2025

Ever-Glory International Group, Inc., together with its subsidiaries, manufactures, supplies, and retails apparel in Mainland China, Hong Kong, Germany, the United Kingdom, Europe, Japan, and the United States. It operates through two segments, Wholesale and Retail. The company primarily offers casual wear, outerwear, and sportswear. Its products include coats, jackets, slacks, skirts, shirts, trousers, and jeans for women; vests, jackets, trousers, skiwear, shirts, coats, and jeans for men; and coats, vests, down jackets, trousers, knitwear, and jeans for children. The company offers its woman apparel under the La go go, Velwin, Sea To Sky, Jizhu, and idole brands. It also engages in the import and export of apparel, fabric, and accessories. The company provides its products directly to consumers through retail stores, as well as online stores at Tmall, Dangdang mall, JD.com, VIP.com, etc. As of March 31, 2022, it operated 848 stores in China. The company is based in Nanjing, the Peoples Republic of China.

MGO Global NASDAQ:MGOL

$0.31 -0.16 (-33.76%)

Closing price 02/19/2025

Extended Trading

$0.31 0.00 (0.00%)

As of 02/19/2025 08:00 PM Eastern

MGO Global, Inc. operates as a lifestyle brand portfolio company. The company is involved in the fashion design, brand development and management, sourcing and manufacturing, licensing, IP protection, corporate finance, consumer engagement and experience, ecommerce, and retail sales and marketing activities related to the Messi brand. MGO Global, Inc. was founded in 2018 and is headquartered in Fort Lauderdale, Florida.

ON NYSE:ONON

$52.35 -3.38 (-6.07%)

Closing price 03:59 PM Eastern

Extended Trading

$52.25 -0.10 (-0.19%)

As of 04:51 PM Eastern

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

Silo Pharma NASDAQ:SILO

$0.59 -0.02 (-3.72%)

Closing price 04:00 PM Eastern

Extended Trading

$0.58 0.00 (-0.58%)

As of 04:46 PM Eastern

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time